相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT
S. McCann et al.
BONE MARROW TRANSPLANTATION (2009)
Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
E. Schmidt et al.
ANNALS OF ONCOLOGY (2008)
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT)
John E. Levine et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
Antonio Palumbo et al.
BLOOD (2008)
Prospective Oral Mucositis Audit: Oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy - European blood and marrow transplantation mucositis advisory group
Nicole Blijlevens et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesus F. San Miguel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products
A. Gratwohl et al.
BONE MARROW TRANSPLANTATION (2008)
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial
Thierry Facon et al.
LANCET (2007)
Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis
N. Blijlevens et al.
ANNALS OF ONCOLOGY (2007)
Updated clinical practice guidelines for the prevention and treatment of mucositis
Dorothy M. Keefe et al.
CANCER (2007)
Effect of renal function on the pharmacokinetics of palifermin
B. Gillespie et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy
Lee S. Rosen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)
Bruce R. Blazar et al.
BLOOD (2006)
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model
M. L. Grazziutti et al.
BONE MARROW TRANSPLANTATION (2006)
Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma
Roland Fenk et al.
EXPERIMENTAL HEMATOLOGY (2006)
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study
Jennifer M. Bird et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation
K. Lilleby et al.
BONE MARROW TRANSPLANTATION (2006)
Assessment of oral mucositis in clinical trials: Impact of training on evaluators in a multi-centre trial
MA Stokman et al.
EUROPEAN JOURNAL OF CANCER (2005)
High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study
R Fenk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy:: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival
K Carlson
BONE MARROW TRANSPLANTATION (2005)
Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients
Y Aisa et al.
SUPPORTIVE CARE IN CANCER (2005)
Palifermin for oral mucositis after intensive therapy for hematologic cancers
R Spielberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Perspectives on cancer therapy-induced mucosal injury - Pathogenesis, measurement, epidemiology, and consequences for patients
ST Sonis et al.
CANCER (2004)
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
JA Child et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant
NJ Meropol et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Results of autologous stem cell transplant in multiple myeloma patients with renal failure
A Badros et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
